The recognition highlights our continued growth, innovation, and commitment to excellence in Pharmacovigilance Industry.
Being part of the Forbes India Select 200 – DGEMS 2024, is a testament to the hard work and dedication of our incredible team. It reflects our relentless pursuit of core values like customer satisfaction, cutting-edge technology, affordability, agility, sustainability, etc. and our vision that until such time we empower humanity with the fundamental right of “Affordable Health for All”, we shall strive for constant path breaking innovation.
This recognition by Forbes underscores our ability to adapt to changing market dynamics and lead with innovative solutions. As we continue to grow and evolve, we remain committed to driving positive change, fostering strong relationships with our partners and clients, and creating long-term value for our stakeholders.
We extend our deepest gratitude to our employees, customers, investors, and all who have been part of this journey. This achievement would not have been possible without your ongoing support.
Mohit Gupta, Vitrana CEO said “We are honoured to be recognised by Forbes India alongside such a distinguished list of companies. Today, we are servicing organizations spread over five continents, but our penetration can further be enhanced and increased to make sure that we touch life of 7 billion people globally. As part of our strategy, we have been investing heavily in research and design in expanding our offering list and making it more compatible with the upcoming Generative AI capabilities and making sure that we become more affordable and accessible to the masses. Forbes India, DGEMS is a wonderful platform. It brings the smartest of the minds and successful brains together. I have even identified as I speak today multiple organizations who are part of DGEMS global list of 200 and are doing business like what we are doing in our domain. Partnering with them will make sure that we have new service offerings co-developed with these organizations and create a much stronger reach.”
Click to watch the exclusive interview.
Stay tuned for more updates as we strive to maintain our leadership and build an even stronger future together.
About Vitrana
Vitrana offers Life sciences and healthcare software platform supporting both SaaS and on-premises deployment with process automation, data driven business optimization, open-integration, data standardization, enterprise search, analytics, and predictive outcomes, reducing total cost of operations and enhancing regulatory compliance and patient safety. Vitrana also provides software consulting and turnkey solutions through automation of work processes, Automation through ML, NLP & Deep Learning, data migration, integration, hosting and cloud adoption, application management support, validation, business configuration and point solutions within the fields of drug safety, regulatory compliance, and outcomes research.
About Forbes India Select 200 – DGEMS 2024
The Forbes India Select 200 – DGEMS (Dynamic Growth Entrepreneurs and Market Shapers) is an exclusive recognition program that celebrates companies demonstrating exceptional growth potential and industry leadership on a global scale. Curated by Forbes India in collaboration with DGlobalist, the DGEMS list highlights businesses that are transforming industries through innovation, scalability, and impact. It serves as a platform to spotlight high-performing enterprises breaking geographical barriers and shaping the future of their sectors.
